First Trust Advisors »

Halozyme Therapeutics shares owned by First Trust Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by First Trust Advisors from 13F filings

Historical chart of First Trust Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by First Trust Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by First Trust Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $49M 1.2M 40.68
2023-09-30 $289k 7.6k 38.20
2023-06-30 $202k 5.6k 36.07
2023-03-31 $4.0M 105k 38.19
2022-12-31 $3.1M 54k 56.90
2022-09-30 $4.4M 111k 39.54
2022-06-30 $3.5M 81k 44.00
2022-03-31 $2.1M 52k 39.87
2021-12-31 $2.3M 57k 40.21
2021-09-30 $5.0M 122k 40.68
2021-06-30 $3.8M 84k 45.41
2021-03-31 $5.8M 139k 41.69
2020-12-31 $3.5M 83k 42.71
2020-09-30 $1.6M 60k 26.27
2020-06-30 $2.7M 100k 26.81
2020-03-31 $245k 14k 17.98
2019-09-30 $669k 43k 15.51
2019-03-31 $1.6M 98k 16.10
2018-12-31 $1.2M 82k 14.63
2018-09-30 $655k 36k 18.18
2018-06-30 $2.7M 159k 16.87
2018-03-31 $1.7M 85k 19.59
2017-12-31 $1.6M 78k 20.26
2017-09-30 $652k 38k 17.37
2017-06-30 $912k 71k 12.83
2017-03-31 $203k 16k 12.96
2016-12-31 $1.1M 108k 9.88